Home > Protocol Summaries: Compounds > Non-GSK Asset Studies Protocol Summaries: Non-GSK Asset Studies GSKStudy ID Phase Title Status 113236 phase 2 A Positron Emission Tomography (PET) Study to evaluate 18FML10 as an imaging agent for tumour apoptosis Completed 113417 n\a Insulin resistance as primary pathogenesis in newly diagnosed, drug naïve type 2 diabetes patients in Korea Completed 113549 phase 1 A positron emission tomography study in healthy male subjects to examine the test-retest reliability of the D2/3 agonist radiotracer [11C]PHNO Completed 113553 phase 4 EU-COAST STUDY: European cost of asthma treatment economic impact of asthma control Completed 113784 phase 1 31P MRS Ischaemic Exercise Optimisation and COPD Myopathy Study Completed 113951 n\a Korean’s practice patterns for screening PCA(prostate cancer) according to PSA(prostate-specific antigen) level Completed 114238 phase 1 An open-label study to evaluate the utility of the apoptosis imaging biomarker 18F]ML10 to assess the response to chemotherapy in patients with Non-Hodgkin's Lymphoma(NHL). Terminated 114427 n\a Risk of pancreatic cancer and renal cancer in patients exposed to gabapentin in the United Kingdom General Practice Research Database Completed 114619 n\a A Nation-wide,multi-center, observational, cross-sectional, epidemiologic study to evaluate the proportion of Cardiovascular disease Risk Factors in Korean hypertensive patients Completed 114777 n\a The prevalence of osteoporotic vertebral compression fractures (OVCF) in Korean post menopausal women Completed 114790 n\a Risk of cancer in patients exposed to gabapentin in the GPRD Completed 114993 n\a SUrvey of Guideline Adherence for treatment of systolic heart failure in Real WorldMulticenter, retrospective observation study in Korea Completed 115241 phase 2 A study to characterize the novel TSPO PET radioligand [18F]PBR111 as an in vivo marker of microglial activation in Multiple Sclerosis Recruiting 115360 phase 1 A Single and Repeat Dose pharmacokinetics/ pharmacodynamics (PK/PD) Study to Characterise theBiomarker Response in Healthy Subjects Treated with the AntiinflammatoryMacrolide Azithromycin Completed 115777 n\a Cardiovascular Events in Cancer Patients Receiving Highly Emetogenic or Moderately Emetogenic Chemotherapy Completed 116015 WEUKBRE5716: Quantifying the burden of steroid-related damage in systemic lupus erythematosus in the Hopkins Lupus Cohort Active not recruiting 116340 Burden of disease and health economic analysis of patients with Benign Prostatic Hyperplasia (BPH) in Brazil Recruiting 116387 Epidemiological multinational (Russia, Ukraine and Kazakhstan), retrospective observational study to evaluate medical, economic and social factors in patients with systemic lupus erythematosus in heading rheumatologic centers Completed 116696 Prevalence of patients infected with CCR5-tropic HIV-1 in Korea Not yet recruiting ADC109043 phase 4 An evaluation of the prevalence of airway obstruction consistent with chronic obstructive pulmonary disease (COPD) in subjects with a history of cigarette smoking and symptoms of chronic bronchitis in a primary care setting Completed SCO104960 phase 4 A multicentre 3 year longitudinal prospective study to identify novel endpoints and compare these with forced expiratory volume in 1 second (FEV1) for their ability to measure and predict COPD severity and its progression over time Completed
